期刊文献+

外科护士在合理使用抗菌药物预防医院感染中的作用 被引量:6

Role of Surgical Nurses in Rational Use of Antibacterials to Prevent Nosocomial Infection
下载PDF
导出
摘要 目的了解医院择期腹腔镜下胆囊切除术执行围手术期使用抗菌药物情况及外科护士在合理使用抗菌药物预防医院感染中的作用。方法对外科、手术室护士进行《浙江省抗菌药物临床合理应用指导方案》培训后,选择2006年1-6月在普外科住院并行胆囊切除的患者,了解使用抗菌药物情况。结果2006年施行的219例腹腔镜下行胆囊切除术,正确执行围手术期合理使用抗菌药物占96%;2005年同期无外科护士的干预,腹腔镜下行胆囊切除术执行围手术期合理使用抗菌药物的只仅占56%。结论有外科护士的参与,腹腔镜下胆囊切除执行围手术期合理使用抗菌药物成效显著。 OBJECTIVE To know the situation of antimicrobial application during laparoscopic cholecystectomy in hospital and the role of surgical nurses in rational use of antibacterials to prevent the nosocomial infection. METHODS To train surgical and operating room nurses on basis of Zhejiang provincial guide scheme on clinical rational use of antibacterials and chooses the patients of department of general surgery after cholecystectomy during Jan to Jun 2006 to know their antibacterial application. RESULTS From 219 cases after laparoscopic cholecystectomy during this period, 96% had rational use of antibacterials during perioperative period vs 56% in the same period of 2005 when were without surgical nurse intervention. CONCLUSIONS The active of surgical nurses is important to significantly elevate the efficacy of rational use of antibacterials during perioperative period.
作者 郑梅
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第2期254-255,214,共3页 Chinese Journal of Nosocomiology
关键词 腹腔镜 胆囊切除 围手术期合理用药 外科护理 医院感染 Laparoscope Cholecystectomy Rational drug use during perioperative period Surgical nursing Nosocomial infection
  • 相关文献

参考文献7

二级参考文献31

  • 1屈玲,府伟灵,徐永涛,陈鸣.166例真菌感染分离鉴定及药敏试验结果分析[J].中华医院感染学杂志,2004,14(1):110-112. 被引量:109
  • 2..医院感染管理规范[S].中华人民共和国卫生部,2000,15-20..
  • 3[1]Jacoby GA,Mederiros AA. More extended-spectrum β-lactamases[J]. Antimicrob Agents Chemother,1991, 35(9):1697-1704.
  • 4[4]Sanders CC,Barry AL, Washington JA, et al. Detection of extended-spectrum β-lactamases-producing members of the family Enterobacteriaceae with the VITEK ESBLs test [J]. J Clin Microbiol, 1996,34(12): 2997-3001.
  • 5[5]Livermore DM. β-Lactamases in laboratory and clinical resistance [J]. J Clin Microbiol Rev, 1995, 8(3): 557-584.
  • 6[6]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement [S]. NCCLS, 1999.19: 36-75.
  • 7[9]Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases [J]. Antimicrob Agents Chemother, 1997, 41(2): 223-232.
  • 8[10]Coudron PE, Molaand ES, Thomoson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microbiol, 2000, 38(5):1791-1796.
  • 9[11]Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J]. J Clin Microbiol, 1996, 34(4): 908-911.
  • 10王虹.临床路径[M].长沙:湖南科学技术出版社,2002:1-36.

共引文献179

同被引文献36

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部